관상동맥 우회술(CABG) 시장 규모, 점유율 및 동향 분석 보고서 : 기법별, 수술별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Coronary Artery Bypass Graft Market Summary

The global coronary artery bypass graft market size was estimated at USD 19.24 billion in 2024 and is projected to reach USD 27.66 billion by 2033, growing at a CAGR of 3.86% from 2025 to 2033. Increasing the prevalence of cardiovascular disease is one of the key aspects driving market growth.

According to an Oxford Academic article published in January 2025, the global burden of cardiovascular disease remains substantial, with an age-standardized prevalence of approximately 7,179 cases per 100,000 individuals. This high prevalence underlines the growing need for effective treatment options, particularly for coronary artery disease, which is a leading contributor to cardiovascular-related morbidity and mortality.

The increasing incidence of CAD drives market growth. According to the CDC article published in October 2024, in the U.S., coronary artery disease (CAD) affects a significant portion of the population, with nearly 1 in 20 adults aged 20 years and older, approximately 5% living with the condition. This sizable patient pool highlights the ongoing clinical challenge posed by CAD, which remains a leading cause of heart-related morbidity and mortality. For many individuals, advanced cases of CAD require surgical intervention when less invasive treatments prove insufficient. As a result, coronary artery bypass grafting (CABG) continues to serve as a vital therapeutic approach, reinforcing its importance within the broader cardiovascular treatment landscape and underscoring its role as a key driver of market demand.

Advancements in graft technology are paving the way for more effective and durable solutions in CABG procedures. For instance, in July 2025, Xeltis, a transformative implant developer, introduced Xabg, a synthetic coronary artery bypass conduit (CABG). This innovative graft is designed to enable the natural creation of living and long-lasting vessels. Preliminary clinical data from an EU clinical trial have demonstrated positive safety and patency outcomes among patients with multi-vessel atherosclerotic coronary artery disease. Xabg represents a significant advancement in graft technology, aiming to address the limitations of traditional grafts by promoting endothelial cell growth and integration with the patient's vascular system.

Moreover, integrating robotics into CABG procedures transforms surgical approaches, offering enhanced precision and reduced invasiveness. According to OAE Publishing Inc., an article published in August 2025, Robotic-assisted CABG has emerged as a minimally invasive alternative to traditional open-heart surgery, offering reduced surgical trauma and faster recovery. Techniques include robotic-assisted minimally invasive direct coronary artery bypass (RA-MIDCAB), where the internal thoracic artery is harvested robotically and anastomosed via mini-thoracotomy, and totally endoscopic CABG (TECAB), which avoids thoracotomy altogether. These advancements reshape operative planning and execution, enhancing precision and reducing invasiveness in coronary revascularization procedures.

The landscape of CABG reimbursement in the U.S. is evolving rapidly, reflecting the healthcare industry's push toward value-based care. A significant trend is the introduction of bundled payment models that streamline reimbursement and incentivize quality. According to the American College of Cardiology Foundation in April 2024, the Centers for Medicare & Medicaid Services (CMS) proposed the Transforming Episode Accountability Model (TEAM), a mandatory hospital episode-based payment model set to start in January 2026. This model bundles payments for CABG surgeries and other high-cost procedures, ensuring more predictable reimbursement and encouraging hospitals to optimize care pathways for improved patient outcomes.

Parallel to bundled payments, physician fee schedule updates have shaped reimbursement trends. According to an Atricure article, effective January 1, 2025, the Medicare Physician Fee Schedule (PFS) revised reimbursement rates for CABG procedures, including the single arterial graft CABG (CPT code 33533) at approximately USD 1,789. These adjustments ensure payments align with current clinical practice and operational costs, reinforcing fair compensation for hospitals and surgeons performing complex cardiac procedures.

Moreover, expanding coverage for minimally invasive CABG techniques reflects increasing acceptance of advanced surgical approaches. As of January 2025, Blue Cross Blue Shield of Rhode Island updated its medical policy to cover Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) surgery. The policy recognizes the benefits of less invasive procedures, such as reduced recovery times and enhanced patient outcomes. However, other minimally invasive approaches, such as Port Access CABG (PACAB) and Total Endoscopic CABG (TECAB), remain excluded due to limited evidence of improved outcomes.

Global Coronary Artery Bypass Graft Market Report Segmentation

This report forecasts revenue and volume growth at global, regional, and country levels and analyzes industry trends in each sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global coronary artery bypass graft market report based on method, surgical procedure, end-use, and region:

• Method Outlook (Revenue USD Million, 2021 - 2033)
• Off-pump
• On-pump
• Minimally Invasive Direct CABG (MIDCAB)
• Surgical Procedure Outlook (Revenue USD Million, 2021 - 2033) (Procedure Volume, In Thousand, 2021 - 2033)
• Single CABG Surgery
• Double CABG Surgery
• Triple CABG Surgery
• Quadruple CABG Surgery
• End-use Outlook (Revenue USD Million, 2021 - 2033)
• Hospitals
• Cardiology Centers
• Others
• Regional Outlook (Revenue USD Million, 2021 - 2033) (Procedure Volume, In Thousand, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Spain
  • Italy
  • France
  • Denmark
  • Norway
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Method outlook
  • 2.2.2. Surgical Procedure outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Coronary Artery Bypass Graft Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising cardiovascular (CVD) and coronary artery disease (CAD) prevalence
    • 3.2.1.2. Technological advances in grafts & robotics
    • 3.2.1.3. Increasing favorable reimbursement policies for CABG
    • 3.2.1.4. Increasing favorable reimbursement policies for CABG
    • 3.2.1.5. AI-Guided Intra-Operative Imaging Adoption
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Operational and procedural hurdles restrict advanced CABG techniques
    • 3.2.2.2. Surgical complexity and associated risks in CABG
• 3.3. Coronary Artery Bypass Graft: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Future Opportunity Analysis
  • 3.4.1. Tissue-Engineered Vascular Grafts (TEVGs)
  • 3.4.2. Growing CABG Demand In High-Risk, Multi-Vessel CAD Patients
  • 3.4.3. AI and Imaging Integration In Pre-Surgical Planning
• 3.5. Technology Landscape
  • 3.5.1. Technological And Procedural Innovations
  • 3.5.2. Advancements In Graft Materials
  • 3.5.3. 3D Printing In Surgical Planning
• 3.6. Clinical & Procedural Trends in the CABG Market
• 3.7. Case Studies
• 3.8. Alternative Methods to CABG

Chapter 4. Coronary Artery Bypass Graft Market Segment Analysis, By Method, 2021 - 2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Method Market Share Analysis, 2024 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Coronary Artery Bypass Graft Market, by Method, 2021 - 2033
• 4.5. Off-pump
  • 4.5.1. Off-pump market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.6. On-pump
  • 4.6.1. On-pump market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.7. Minimally Invasive Direct CABG (MIDCAB)
  • 4.7.1. Minimally Invasive Direct CABG (MIDCAB) market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Coronary Artery Bypass Graft Market Segment Analysis, By Surgical Procedure, 2021 - 2033 (USD Million) (Thousands)

• 5.1. Definition and Scope
• 5.2. Surgical Procedure Market Share Analysis, 2024 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Coronary Artery Bypass Graft Market, by Surgical Procedure, 2021 - 2033
• 5.5. Single CABG Surgery
  • 5.5.1. Single CABG surgery market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5.2. Single CABG surgery market estimates and forecasts, 2021 - 2033 (In Thousand)
• 5.6. Double CABG Surgery
  • 5.6.1. Double CABG surgery market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6.2. Double CABG surgery market estimates and forecasts, 2021 - 2033 (In Thousand)
• 5.7. Triple CABG Surgery
  • 5.7.1. Triple CABG surgery market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7.2. Triple CABG surgery market estimates and forecasts, 2021 - 2033 (In Thousand)
• 5.8. Quadruple CABG Surgery
  • 5.8.1. Quadruple CABG surgery market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.8.2. Quadruple CABG surgery market estimates and forecasts, 2021 - 2033 (In Thousand)

Chapter 6. Coronary Artery Bypass Graft Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

• 6.1. Definition and Scope
• 6.2. End Use Market Share Analysis, 2024 & 2033
• 6.3. Segment Dashboard
• 6.4. Global Coronary Artery Bypass Graft Market, by end use, 2021 - 2033
• 6.5. Hospitals
  • 6.5.1. Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.6. Cardiology Centers
  • 6.6.1. Cardiology Centers market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Coronary Artery Bypass Graft Market Segment Analysis, By Region, By Method, By Surgical Procedure, By End Use, 2021 - 2033 (USD Million)

• 7.1. Regional Market Share Analysis, 2024 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Regional Market Snapshot
• 7.4. Coronary Artery Bypass Graft Market Share by Region, 2024 & 2033:
• 7.5. North America
  • 7.5.1. North America Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory Framework & Reimbursement Scenario
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. U.S. Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.5.2.5. U.S. Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.5.3. Canada
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory Framework & Reimbursement Scenario
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Canada Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.5.3.5. Canada Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.5.4. Mexico
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory Framework & Reimbursement Scenario
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Mexico Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.5.4.5. Mexico Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
• 7.6. Europe
  • 7.6.1. Europe Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory Framework & Reimbursement Scenario
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. UK Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.6.2.5. UK Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.6.3. Germany
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory Framework & Reimbursement Scenario
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Germany Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.6.3.5. Germany Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.6.4. France
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory Framework & Reimbursement Scenario
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. France Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.6.4.5. France Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.6.5. Italy
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory Framework & Reimbursement Scenario
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Italy Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.6.5.5. Italy Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.6.6. Spain
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory Framework & Reimbursement Scenario
    • 7.6.6.3. Competitive Scenario
    • 7.6.6.4. Spain Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.6.6.5. Spain Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.6.7. Norway
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Regulatory Framework & Reimbursement Scenario
    • 7.6.7.3. Competitive Scenario
    • 7.6.7.4. Norway Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.6.7.5. Norway Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.6.8. Sweden
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Regulatory Framework & Reimbursement Scenario
    • 7.6.8.3. Competitive Scenario
    • 7.6.8.4. Sweden Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.6.8.5. Sweden Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.6.9. Denmark
    • 7.6.9.1. Key country dynamics
    • 7.6.9.2. Regulatory Framework & Reimbursement Scenario
    • 7.6.9.3. Competitive Scenario
    • 7.6.9.4. Denmark Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.6.9.5. Denmark Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory Framework & Reimbursement Scenario
    • 7.7.1.3. Competitive Scenario
    • 7.7.1.4. Japan Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.7.1.5. Japan Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory Framework & Reimbursement Scenario
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. China Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.7.2.5. China Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory Framework & Reimbursement Scenario
    • 7.7.3.3. Competitive Scenario
    • 7.7.3.4. India Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.7.3.5. India Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory Framework & Reimbursement Scenario
    • 7.7.4.3. Competitive Scenario
    • 7.7.4.4. Australia Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.7.4.5. Australia Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory Framework & Reimbursement Scenario
    • 7.7.5.3. Competitive Scenario
    • 7.7.5.4. South Korea Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.7.5.5. South Korea Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Regulatory Framework & Reimbursement Scenario
    • 7.7.6.3. Competitive Scenario
    • 7.7.6.4. Thailand Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.7.6.5. Thailand Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory Framework & Reimbursement Scenario
    • 7.8.1.3. Competitive Scenario
    • 7.8.1.4. Brazil Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.8.1.5. Brazil Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.8.2. Argentina
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory Framework & Reimbursement Scenario
    • 7.8.2.3. Competitive Scenario
    • 7.8.2.4. Argentina Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.8.2.5. Argentina Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Regulatory Framework & Reimbursement Scenario
    • 7.9.1.3. Competitive Scenario
    • 7.9.1.4. South Africa Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.9.1.5. South Africa Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Regulatory Framework & Reimbursement Scenario
    • 7.9.2.3. Competitive Scenario
    • 7.9.2.4. Saudi Arabia Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.9.2.5. Saudi Arabia Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Regulatory Framework & Reimbursement Scenario
    • 7.9.3.3. Competitive Scenario
    • 7.9.3.4. UAE Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.9.3.5. UAE Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Regulatory Framework & Reimbursement Scenario
    • 7.9.4.3. Competitive Scenario
    • 7.9.4.4. Kuwait Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.9.4.5. Kuwait Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Profiles
  • 8.3.1. Medtronic
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Product benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. Terumo Corporation
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Getinge AB
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. W. L. Gore & Associates, Inc.
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. B. Braun SE
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Abbott.
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. LivaNova plc
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Transonic
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Edwards Lifesciences
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Vascular Graft Solutions
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives